Loading...

Loading...

Regulations Needed to Boost Mexico’s Biosimilars Market
By Miriam Bello - Mon, 05/02/2022 - 08:41
Biosimilars are an alternative for patients and healthcare systems to manage costs, says Rodrigo Fernández.
https://mexicobusiness.news/tag/biosimilars
More Health
Generics, Biosimilar Leader to Expand Access, Reduce Costs
By Miriam Bello - Wed, 07/21/2021 - 08:30
Through investments in access and innovation, Sandoz strengthens its market positioning.
Cost Savings, Health Through Biosimilars
By Miriam Bello - Fri, 07/02/2021 - 17:19
Biosimilars bring cost savings while delivering excellent quality. Find out the local opportunities in this area.
Biosimilars to Underpin Future Success
By - Wed, 09/05/2018 - 11:31
Sandoz is a division of Novartis dedicated to the production of generics and biosimilars.
Health as a Competitive Engine for the Economy
By - Wed, 09/05/2018 - 09:38
PharmAdvice is a pharmaceutical, biotechnology and healthcare consulting services company.
Integral Legal Solutions for Healthcare Innovation
By - Wed, 09/07/2016 - 14:43
Being a full-services law firm gives B&M a privileged position to assist during the whole life cycle of regulated products.
Prioritizing Access to Global Innovation
By - Wed, 09/09/2015 - 14:26
Amgen has nine biosimilars in development, with the first expected to come to market in 2017.
New Norm to Clear Pathway for Biopharmaceuticals
By - Wed, 09/09/2015 - 12:26
In 2014, Mexican Official Norm NOM-257-SSA1-2014 was published in the DOF, setting out the requirements and specifications for biotechnology medicines
Setting the Global Benchmark for Mexican Biotechnology
By - Wed, 09/09/2015 - 12:14
Today, PROBIOMED is the only company in Mexico that is able to manufacture high-quality products at a low cost.